Novel method for preparing dihydroxy acid HMG CoA reductase inhibitor

A hydroxycarboxylate, alkyl technology, applied in the field of preparing dihydroxyacid HMG-CoA reductase inhibitors, can solve problems such as difficult operation, complex structure, difficult synthesis, etc., and achieves less environmental pollution, high yield, easy effect of operation

Active Publication Date: 2006-08-23
CHANGZHOU YABANG PHARMA
View PDF4 Cites 26 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Due to the complex structure of statins, the synthesis is relatively difficult. There are many synthetic methods in the prior art, but they all have defects such as low yiel

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel method for preparing dihydroxy acid HMG CoA reductase inhibitor
  • Novel method for preparing dihydroxy acid HMG CoA reductase inhibitor
  • Novel method for preparing dihydroxy acid HMG CoA reductase inhibitor

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0057] Example 1: Preparation of compound (B) 4-(4-fluorobenzene)-6-isopropyl-2-(N-methyl-N-methanesulfonylamino)-5-pyrimidinecarbaldehyde:

[0058]Add 28.0 g of pyridinium chlorochromate (PCC) and 24.6 g of anhydrous sodium acetate to 300 ml of dry dichloromethane, stir, and add compound (A) [4-(4-fluorobenzene)-6-iso] dropwise at 20°C. Propyl-2-(N-methyl-N-methanesulfonylamino)pyrimidin-5-yl]methanol 35.3g and 200ml dichloromethane prepared solution, stirred for 1h, filtered, the filtrate 1N hydrochloric acid 500ml, 1N NaOH 500ml, Wash with 500 ml of saturated brine, dry with anhydrous magnesium sulfate, remove dichloromethane under reduced pressure, column chromatography of the residue, eluent dichloromethane, to obtain 29.1 g of the crystalline target product (yield: 82.9%).

Example Embodiment

[0059] Example 2: Preparation of Compound (D):

[0060] Add 13.0 g of trimethyl phosphite to 200 ml of toluene, heat to reflux, and add compound (C) 2-[(4R, 6S)-6-bromomethyl-2,2-dimethyl-1,3-dioxe dropwise A solution of 32.3g of tert-butyl acetate and 200ml of toluene, reflux for 3h, remove toluene under reduced pressure, add 500ml of water, extract with 200ml×3 of chloroform, dry with anhydrous magnesium sulfate, remove chloroform under reduced pressure, The residue was subjected to column chromatography and ethyl acetate as the eluent to obtain 31.7 g of the target product (yield: 90.1%).

Example Embodiment

[0061] Example 3: Preparation of Compound (E)

[0062] Under the protection of argon, add 15.3g of LiCl and 42.2g of compound (D) to 300ml of dry dichloromethane, stir, add 12.2g of triethylamine dropwise at 0°C, and then add 35.1g of compound (B) and dichloromethane dropwise. 200ml of the prepared solution, stirred at 20°C for 1 hour, added 300ml of saturated ammonium chloride solution to the reaction solution, separated into layers, extracted with 200ml of dichloromethane in the aqueous phase, combined the organic phases, dried over anhydrous magnesium sulfate, and removed under reduced pressure. Chloromethyl, column chromatography of the residue, eluent (n-hexane: ethyl acetate = 5:1), to obtain 40.7 g of the target product (yield: 70.5%).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides the preparation process of the compound as shown.

Description

Technical field: [0001] The present invention relates to a new method for preparing dihydroxy acid HMG-CoA reductase inhibitors. Background technique: [0002] Dihydroxy acid HMG-CoA reductase inhibitors, also known as: 3-hydroxy-3-methylglutaryl-coenzyme reductase inhibitor A (3-hydroxy-3-methylglutaryl-coenzymeA, HMG-CoA), is a class of A new type of blood lipid-lowering drug, currently the drug of choice for clinical prevention and treatment of atherosclerosis. [0003] Since the first statin drug mevastatin (mevastatin) came out in 1976, statin drugs have developed to the third generation. At present, there are five kinds of statin drugs commonly used in the world (in order of appearance): lovastatin (lovastatin), pravastatin (pravastatin), simvastatin (simvastatin), fluvastatin (fluvastatin) and atorvastatin (atorvastatin). Not long ago, cerivastatin (cerivastatin), which has a powerful lipid-lowering effect and is only used in micrograms, has been used in the intern...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D405/06C07D239/42A61P9/10
Inventor 王思清吴宾徐树行
Owner CHANGZHOU YABANG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap